FMT has shown remarkable efficacy in treating recurrent CDI, with success rates exceeding 90% in some studies. Traditional treatments, including antibiotics like vancomycin and metronidazole, often fail to prevent recurrence. The high success rate of FMT underscores its potential as a first-line treatment for recurrent CDI, which is particularly important given the rising prevalence of antibiotic resistance.
